153 related articles for article (PubMed ID: 37947974)
1. Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Pfob A; Cai L; Schneeweiss A; Rauch G; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Degenhardt T; Rom J; Rody A; van Mackelenbergh M; Banys-Paluchowski M; Große R; Reinisch M; Karsten MM; Sidey-Gibbons C; Wallwiener M; Golatta M; Heil J
Ann Surg Oncol; 2024 Feb; 31(2):957-965. PubMed ID: 37947974
[TBL] [Abstract][Full Text] [Related]
2. Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.
Pfob A; Sidey-Gibbons C; Rauch G; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Degenhardt T; Rom J; Rody A; van Mackelenbergh M; Banys-Paluchowski M; Große R; Reinisch M; Karsten M; Golatta M; Heil J
J Clin Oncol; 2022 Jun; 40(17):1903-1915. PubMed ID: 35108029
[TBL] [Abstract][Full Text] [Related]
3. RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.
Heil J; Sinn P; Richter H; Pfob A; Schaefgen B; Hennigs A; Riedel F; Thomas B; Thill M; Hahn M; Blohmer JU; Kuemmel S; Karsten MM; Reinisch M; Hackmann J; Reimer T; Rauch G; Golatta M
BMC Cancer; 2018 Aug; 18(1):851. PubMed ID: 30144818
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.
Heil J; Pfob A; Sinn HP; Rauch G; Bach P; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Ditsch N; Rody A; Große R; van Mackelenbergh M; Reinisch M; Karsten M; Golatta M;
Ann Surg; 2022 Mar; 275(3):576-581. PubMed ID: 32657944
[TBL] [Abstract][Full Text] [Related]
5. Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients.
Koelbel V; Pfob A; Schaefgen B; Sinn P; Feisst M; Golatta M; Gomez C; Stieber A; Bach P; Rauch G; Heil J
Ann Surg Oncol; 2022 Feb; 29(2):1076-1084. PubMed ID: 34581923
[TBL] [Abstract][Full Text] [Related]
6. Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial.
Lee HB; Han W; Kim SY; Cho N; Kim KE; Park JH; Ju YW; Lee ES; Lim SJ; Kim JH; Ryu HS; Lee DW; Kim M; Kim TY; Lee KH; Shin SU; Lee SH; Chang JM; Moon HG; Im SA; Moon WK; Park IA; Noh DY
Breast Cancer Res Treat; 2020 Jul; 182(1):97-105. PubMed ID: 32418044
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer.
Tasoulis MK; Lee HB; Yang W; Pope R; Krishnamurthy S; Kim SY; Cho N; Teoh V; Rauch GM; Smith BD; Valero V; Mohammed K; Han W; MacNeill F; Kuerer HM
JAMA Surg; 2020 Dec; 155(12):e204103. PubMed ID: 33026457
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence to de-escalate loco-regional breast cancer treatment.
Pfob A; Heil J
Breast; 2023 Apr; 68():201-204. PubMed ID: 36842193
[TBL] [Abstract][Full Text] [Related]
9. Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment).
van der Noordaa MEM; van Duijnhoven FH; Loo CE; van Werkhoven E; van de Vijver KK; Wiersma T; Winter-Warnars HAO; Sonke GS; Vrancken Peeters MTFD
Breast; 2018 Aug; 40():76-81. PubMed ID: 29698928
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
Bossuyt V; Provenzano E; Symmans WF; Boughey JC; Coles C; Curigliano G; Dixon JM; Esserman LJ; Fastner G; Kuehn T; Peintinger F; von Minckwitz G; White J; Yang W; Badve S; Denkert C; MacGrogan G; Penault-Llorca F; Viale G; Cameron D;
Ann Oncol; 2015 Jul; 26(7):1280-91. PubMed ID: 26019189
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of Magnetic Resonance Imaging-Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial.
Sutton EJ; Braunstein LZ; El-Tamer MB; Brogi E; Hughes M; Bryce Y; Gluskin JS; Powell S; Woosley A; Tadros A; Sevilimedu V; Martinez DF; Toni L; Smelianskaia O; Nyman CG; Razavi P; Norton L; Fung MM; Sedorovich JD; Sacchini V; Morris EA
JAMA Netw Open; 2021 Jan; 4(1):e2034045. PubMed ID: 33449096
[TBL] [Abstract][Full Text] [Related]
12. Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?
Heil J; Schaefgen B; Sinn P; Richter H; Harcos A; Gomez C; Stieber A; Hennigs A; Rauch G; Schuetz F; Sohn C; Schneeweiss A; Golatta M
Eur J Cancer; 2016 Dec; 69():142-150. PubMed ID: 27821317
[TBL] [Abstract][Full Text] [Related]
13. Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.
Sun S; van la Parra RFD; Rauch GM; Checka C; Tadros AB; Lucci A; Teshome M; Black D; Hwang RF; Smith BD; Krishnamurthy S; Valero V; Yang WT; Kuerer HM
Ann Surg Oncol; 2019 Oct; 26(10):3071-3079. PubMed ID: 31342361
[TBL] [Abstract][Full Text] [Related]
14. Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy.
Pfob A; Sidey-Gibbons C; Lee HB; Tasoulis MK; Koelbel V; Golatta M; Rauch GM; Smith BD; Valero V; Han W; MacNeill F; Weber WP; Rauch G; Kuerer HM; Heil J
Eur J Cancer; 2021 Jan; 143():134-146. PubMed ID: 33307491
[TBL] [Abstract][Full Text] [Related]
15. Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer?
Cai L; Sidey-Gibbons C; Nees J; Riedel F; Schäfgen B; Togawa R; Killinger K; Heil J; Pfob A; Golatta M
Eur Radiol; 2024 Apr; 34(4):2560-2573. PubMed ID: 37707548
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant systemic therapy for breast cancer: the Westmead experience.
Cocco AM; Messer D; Brown A; Sriram N; Gilchrist J; Al-Mansouri L; Kefford R; Meybodi F; French J; Hsu J; Elder E
ANZ J Surg; 2018 Jun; 88(6):640-644. PubMed ID: 28922685
[TBL] [Abstract][Full Text] [Related]
17. Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy.
Barron AU; Hoskin TL; Day CN; Hwang ES; Kuerer HM; Boughey JC
JAMA Surg; 2018 Dec; 153(12):1120-1126. PubMed ID: 30193375
[TBL] [Abstract][Full Text] [Related]
18. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.
Kuerer HM; Rauch GM; Krishnamurthy S; Adrada BE; Caudle AS; DeSnyder SM; Black DM; Santiago L; Hobbs BP; Lucci A; Gilcrease M; Hwang RF; Candelaria RP; Chavez-MacGregor M; Smith BD; Arribas E; Moseley T; Teshome M; Miggins MV; Valero V; Hunt KK; Yang WT
Ann Surg; 2018 May; 267(5):946-951. PubMed ID: 28549010
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients.
Hayashi N; Tsunoda H; Namura M; Ochi T; Suzuki K; Yamauchi H; Nakamura S
Clin Breast Cancer; 2019 Feb; 19(1):71-77. PubMed ID: 30206035
[TBL] [Abstract][Full Text] [Related]
20. Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients-a single institution experience.
Pislar N; Gasljevic G; Music MM; Borstnar S; Zgajnar J; Perhavec A
World J Surg Oncol; 2023 Sep; 21(1):292. PubMed ID: 37715188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
